# Empower Neuromodulation System - Pilot Study for Anxiety Treatment

> **NCT04901481** · NA · TERMINATED · sponsor: **Theranova, L.L.C.** · enrollment: 18 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DEVICE:** Empower Neuromodulation System

## Key facts

- **NCT ID:** NCT04901481
- **Lead sponsor:** Theranova, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-17
- **Primary completion:** 2022-07-28
- **Final completion:** 2023-05-17
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Unable to fully enroll study.
- **Last updated:** 2024-06-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04901481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04901481, "Empower Neuromodulation System - Pilot Study for Anxiety Treatment". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04901481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*